Approaches to the treatment of disease induced by chikungunya virus

被引：0
|
作者：
Bettadapura, Jayaram [1 ]
Herrero, Lara J. [1 ]
Taylor, Adam [1 ]
Mahalingam, Suresh [1 ]
机构：
[1] Griffith Univ, Inst Glyc, Emerging Viruses & Inflammat Res Grp, Nathan, Qld 4222, Australia
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2013年 / 138卷
基金：
英国医学研究理事会;
关键词：
Antivirals; arthralgia; chikungunya; CHIKV; vaccines; MOUSE MODEL; ANTIVIRAL ACTIVITY; VACCINE; ARTHRITIS; REPLICATION; INHIBITION; INFECTION; IMMUNOGENICITY; IDENTIFICATION; EPIDEMIC;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Chikungunya virus, a re-emerging mosquito-borne alphavirus, causes fever, rash and persistent arthralgia/arthritis in humans. Severe outbreaks have occurred resulting in infections of millions of people in Southeast Asia and Africa. Currently there are no antiviral drugs or vaccines for prevention and treatment of chikungunya infections. Herein we report the current status of research on antiviral drugs and vaccines for chikungunya virus infections.
引用
收藏
页码：762 / 765
页数：4
相关论文
共 50 条
  • [41] Chikungunya virus and prospects for a vaccine
    Weaver, Scott C.
    Osorio, Jorge E.
    Livengood, Jill A.
    Chen, Rubing
    Stinchcomb, Dan T.
    EXPERT REVIEW OF VACCINES, 2012, 11 (09) : 1087 - 1101
  • [42] Neurologic Manifestation of Chikungunya Virus
    Brizzi, Kate
    CURRENT INFECTIOUS DISEASE REPORTS, 2017, 19 (02)
  • [43] Origins, pathophysiology, diagnosis, vaccination and prevention of Chikungunya virus
    Rafei, Md Rajdoula
    Ahmed, Syeda Naureen
    Ahmed, Zebunnesa
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2019, 32 (01) : 40 - 44
  • [44] A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus
    Brandler, Samantha
    Ruffle, Claude
    Combredet, Chantal
    Brault, Jean-Baptiste
    Najburg, Valerie
    Prevost, Marie-Christine
    Habel, Andre
    Tauber, Erich
    Despres, Philippe
    Tangy, Frederic
    VACCINE, 2013, 31 (36) : 3718 - 3725
  • [45] Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential
    Webb, Emily M.
    Azar, Sasha R.
    Haller, Sherry L.
    Langsjoen, Rose M.
    Cuthbert, Candace E.
    Ramjag, Anushka T.
    Luo, Huanle
    Plante, Kenneth
    Wang, Tian
    Simmons, Graham
    Carrington, Christine V. F.
    Weaver, Scott C.
    Rossi, Shannan L.
    Auguste, Albert J.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] Antiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti Mosquitoes
    Mishra, Priya
    Furey, Colleen
    Balaraman, Velmurugan
    Fraser, Malcolm J., Jr.
    VIRUSES-BASEL, 2016, 8 (06):
  • [47] Generation of a Live-Attenuated Strain of Chikungunya Virus from an Indian Isolate for Vaccine Development
    Nair, Sreeja R. R.
    Abraham, Rachy
    Sreekumar, Easwaran
    VACCINES, 2022, 10 (11)
  • [48] A Critical Role for STING Signaling in Limiting Pathogenesis of Chikungunya Virus
    Geng, Tingting
    Lin, Tao
    Yang, Duomeng
    Harrison, Andrew G.
    Vella, Anthony T.
    Fikrig, Erol
    Wang, Penghua
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (12) : 2186 - 2196
  • [49] Recent progress on chikungunya virus research
    An, Wenxi
    Ge, Ningning
    Cao, Yilin
    Sun, Jin
    Jin, Xia
    VIROLOGICA SINICA, 2017, 32 (06) : 441 - 453
  • [50] Imported fever due to Chikungunya virus
    Martin-Farfan, Adolfo
    Calbo-Torrecillas, Francisco
    Perez-de Pedro, Ivan
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (06): : 343 - 344
12345